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Abstract 
The Morita-Baylis-Hillman (MBH) reaction is a carbon-carbon bond forming transformation between an 
electrophile, typically an aldehyde, and an activated olefin. MBH adducts obtained from 2-hydroxy-
benzaldehydes and cyclic enones are potential substrates for the synthesis of xanthenone and chromenone 
derivatives. In this work, we investigated conditions to obtain tetrahydro-1H-xanthen-1-ones and chromen-
1-ones directly via a Morita-Baylis-Hillman/oxa-Michael/elimination cascade catalyzed by a bifunctional, 
bicyclic imidazolyl alcohol (BIA), which proved to be an effective catalyst for this transformation. The 
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Introduction 
 
The Morita-Baylis-Hillman (MBH) reaction is a carbon-carbon bond forming transformation between an 
electrophile and an activated olefin, typically catalysed by a Lewis base, to form most commonly α-
methylene-β-hydroxycarbonyl species.1–3 Due to the high functionalization degree of the adducts obtained 
from MBH reactions, they have been employed in the synthesis of a variety of heterocycles.4–9 
Among the examples of oxygenated heterocycles, a class that has not been particularly explored is the 
tetrahydroxanthenones and chromenones and the possibility of obtaining them from the reaction of 
2-hydroxybenzaldehydes and cyclic enones. These compounds are important heterocycles with a wide range 
of biological activities such as antimicrobial, antifungal and anticancer.10–13 Tricyclic chromenones also figure 








Scheme 1.  Previously reported17-19 syntheses of racemic tetrahydroxanthenone and chromen-1-one 
derivatives from 2-hydroxybenzaldehydes and cyclic enones. 
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The methodologies described so far for obtaining these moieties from 2-hydroxybenzaldehydes and 
activated olefins in a single step are summarized in Scheme 1.17–19 
In the first description of this transformation, Bräse et al. found that DABCO in water was able to 
provide in a single step tetrahydroxanthenone derivatives in yields ranging from poor to excellent.17 In this 
work, the authors were not able to intercept the MBH adduct, and thus proposed a mechanism in which the 
first step was the oxa-Michael addition followed by an aldol condensation step. In 2005 Shi et al. prepared 
tetrahydroxanthenones and chromenone derivatives by reacting salicyl N-tosylimines with cyclic enones 
using a phosphine as the catalyst.18 Contrasting with Bräse’s results, the authors intercepted the aza-MBH 
adducts, indicating that the overall transformation might also proceed firstly by a MBH step. In their 
protocol, an additional step with DBU was necessary to promote elimination and the overall yields ranged 
from moderate to excellent.  In 2010,19 Bräse et al. employed the same catalytic system developed by Shi et 
al. with salicylaldehydes, obtaining the corresponding tetrahydroxanthenones in poor to quantitative yields 
(most examples in less than 65 % yield). The authors concluded that the MBH pathway could be an 
alternative with less basic catalysts such as phosphines. 
In the present work we describe the use of a bicyclic imidazolyl alcohol (BIA) as a new bifunctional 
organocatalyst for the synthesis of tetrahydroxanthenones and tricyclic chromenones from the direct 




Results and Discussion 
 
We began our investigation with the reaction of salicylaldehyde (1a) and 2-cyclohexen-1-one (2a) as model 
reaction, and screened a series of parameters. Our group has previously shown that BIA is an excellent 
catalyst for the aqueous MBH reaction in which cyclic enones are the nucleophilic partners.20–22 Given the 
evidence that the reaction might be proceeding through the MBH adduct,19 we decided to test this catalytic 
system in the synthesis of the tetrahydroxanthenone 3a and to compare it with catalysts already known to 
perform this transformation (Table 1).  
We first tested the use of equimolar quantities of salicylaldehyde and 2-cyclohexen-1-one, 50 mol% of 
BIA and 10 mol% of sodium dodecyl sulfate (SDS) in water, and, after 60 hours, the tetrahydroxanthenone 
3a was obtained in 58 % yield (entry 1). In order to check if we could improve this yield, knowing that BIA 
provides best results in aqueous conditions, we tested different solvent combinations with water (entries 2-
5). However, no improvement was observed and, in fact, all results were inferior to those in pure water. We 
also evaluated the neat transformation, but the yield was also low (entry 6). Thus, water was established as 
the optimal solvent for the reaction.  
We also evaluated the impact of catalyst loading of BIA to the yield of 3a. The use of only 20 mol% of 
BIA led to an unsatisfactory yield of 30 % (entry 7). When 65 mol% of BIA was used, however, a slightly 
enhanced yield was observed (entry 8). A further increase in the catalyst loading to 100 mol% did not 
improve the isolated yield (entry 9). Having fixed 65 mol% of BIA as an optimal catalyst charge, we then 
evaluated the number of 2-cyclohexen-1-one equivalents in relation to salicylaldehyde (entries 10-12). The 
reaction performed better when excess of 2a was employed, and the use of 2.0 equivalents of the 2-
cycloenone led to a 68 % isolated yield of 3a (77 % yield considering the recovery of unreacted 
salicylaldehyde). Increasing the temperature of the reaction did not improve the yields (entries 13 and 14). 
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Thus, the optimal conditions were defined as 0.65 equiv. of BIA, 2.0 equiv. of 2-cycloenone and water as the 
solvent at room temperature (entry 11). In order to compare our protocol with the one reported in the 
literature by Bräse et al., we performed the reaction of 1a in the same conditions as reported by the authors 
(entry 15).17 Unfortunately, we were not able to reproduce the yield described by Bräse. We also tested the 
use of imidazole as catalyst, which is a structurally simple catalyst compared to BIA (entry 16). However, the 
isolated yield was lower (60 %), confirming the importance of the bifunctional nature of the BIA catalyst to 
furnish 3a in higher yields. 
 















1 1.0 1.0 BIA, 0.50 H2O (1 mL) 10 58c 
2 1.0 1.0 BIA, 0.50 H2O (0.65 mL) : Dioxane (0.35 mL) 10 23c 
3 1.0 1.0 BIA, 0.50 H2O (0.65 mL) : Dioxane (0.35 mL) - 25c 
4 1.0 1.0 BIA, 0.50 Glycerol (1 mL) - 18c 
5 1.0 1.0 BIA, 0.50 Dioxane (1 mL) - 10c 
6 1.0 1.0 BIA, 0.50 - - 13c 
7 1.0 1.0 BIA, 0.20 H2O (1 mL) 10 30c 
8 1.0 1.0 BIA, 0.65 H2O (1 mL) 10 61c 
9 1.0 1.0 BIA, 1.00 H2O (1 mL)  10 60c 
10 1.0 1.5 BIA, 0.65 H2O (1 mL) 10 63c 
11 1.0 2.0 BIA, 0.65 H2O (1 mL) 10 68c,d 
12 2.0 1.0 BIA, 0.65 H2O (1 mL) 10 52c 
13 1.0 2.0 BIA, 0.65 H2O (1 mL) 10 53c,e 
14 1.0 2.0 BIA, 0.65 H2O (1 mL) 10 38f 
15 1.0 1.0 DABCO, 0.50 H2O (0.65 mL) : Dioxane (0.35 mL) - 58c,g 
16 1.0 2.0 Imidazole, 0.65 H2O (1 mL) 10 60c 
a Sodium dodecyl sulfate (SDS) was used as additive; b isolated yields; c recovery of the limiting starting 
material; d 77 % yield, based on recovery of salicylaldehyde (1a); e run at 75 °C;  f run at 100 °C; g reaction 
time: 48 h 
 
With the optimized conditions, we moved on to evaluate the scope of the reaction by applying seven 
different salicylaldehydes and six different 2-cycloenones (Scheme 2). The yields reported are all isolated 
yields after complete consumption of the starting materials or stagnation of the reaction (as confirmed by 1H 
NMR of a crude sample). Electron-rich salicylaldehydes gave generally better yields than electron-deficient 
Arkivoc 2020, ii, 0-0  Rodrigues, M. T. et al. 
 
 Page 5  ©AUTHORS 
ones with 2-cyclohexen-1-one. The lowest yield of the 2-cyclohexen-1-one series was when 2-formyl-β-
naphthol was the coupling partner.  
When 4-bromo-2-hydroxybenzaldehyde was employed, besides the expected product (3f), we also 
noticed significant formation of 4a, a product from the aldol condensation of 3f with a second molecule of 
aldehyde. When 2-cyclopenten-1-one was used as reactant, the obtained yields were generally lower and, 
with electron rich aldehydes, we also observed the formation of the aldol-condensation products (4b and 
4c). With electron poor aldehydes, we did not observe aldol-condensation products, nevertheless, we were 
able to isolate the intermediates MBH adducts (5a and 5b). To the best of our knowledge, this is the first 
time these MBH adducts are isolated. In addition, in presence of BIA catalyst and in aqueous medium, MBH 
adduct 5a slowly converts to dihydrocyclopenta[b]chromen-1(2H)-one 3j (35 % yield of 3j after 5 days of 
reaction). These empirical observations are a strong evidence that the reaction proceeds via an MBH 
reaction followed by oxa-Michael/elimination steps under our conditions, and not the opposite way. With 2-
cyclohepten-1-one as the coupling partner, a low yield (13 %) of the expected product was observed. An 
extensive degradation of compound 3m was observed by thin-layer chromatography during the reaction, 
which might explain the reduced yield. Gem-disubstituted 2-cyclohexen-1-ones at position 4 or 5 did not 
give the desired products 3n, 3o and 3p after 7 days of reaction time. This is probably due to a combination 
of stereoelectronic and steric factors, which might hinder the 1,4-addition of the BIA catalyst to the 
cycloenone.23 
To demonstrate the feasibility of this reaction, we ran an essay on a gram scale. The reaction between 
salicylaldehyde (1a, 8.46 mmol) and cyclohexenone (2 equiv.) provided the xanthenone 3a in 63 % yield 
(1.07 g), after 5 days at room temperature. 
A single crystal of 4c could be obtained and analyzed by X-ray diffraction and its ORTEP diagram is shown 
in Figure 2 (CCDC 1980794). This compound co-crystallized with chloroform and is a definitive proof of the 
structure of the aldol condensation product and the geometry of the double bond.  
 
Figure 2.  ORTEP diagram of compound 4c co-crystallized with chloroform, with 50 % probability 
displacement ellipsoids. The crystallographic details are available in the Supplementary Material. 
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Scheme 2.  Scope of the reaction. 
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Conclusions 
 
In this work, we developed a new catalytic system to obtain tetrahydro-1H-xanthen-1-ones and fused 
chromen-1-ones derivatives directly from the corresponding 2-hydroxybenzaldehydes and 2-cycloenones. 
The reaction proceeds under catalysis of a bifunctional, bicyclic imidazole alcohol (BIA) using water as 
solvent, and several examples were synthetized in low to good yields. We believe that under our optimized 
conditions this transformation involves a Morita-Baylis-Hillman step followed by cyclization (oxa-
Michael/elimination steps), which is in contrast to what has previously been published in the literature. 
Strong evidence for this proposition is the isolation of the MBH adducts 5a and 5b. The synthesized products 
will be screened for potential biological applications and we are currently exploring the possibility of an 





General. All reagents were used from commercial suppliers without further purification. BIA catalyst was 
readily prepared according to a previously reported procedure.24 The reaction progress was monitored by 
thin layer chromatography on silica gel-coated aluminium foils. The products were revealed under UV light 
(254 nm), followed by staining with 25 % phosphomolybdic acid solution in ethanol or with sulfuric vanillin 
and heating with a heat gun. Reaction products were purified by flash column chromatography using silica 
gel (230-400 mesh). 1H NMR and 13C NMR spectra were acquired on a Bruker Avance 250 (250 MHz for 1H 
NMR and 63 MHz for 13C NMR); Bruker Avance 400 (400 MHz for 1H NMR and 101 MHz for 13C NMR) or 
Bruker Avance 500 (500 MHz for 1H and 126 MHz for 13C NMR). Chemical shifts (δ) were reported in ppm 
and the coupling constants (J) in Hertz (Hz). Signal multiplicity was assigned as singlet (s), broad singlet (brs), 
doublet (d), double doublet (dd), double triplet (dt), double double doublet (ddd), double double triplet 
(ddt), triplet (t), triple doublet (td), quartet (q). High resolution mass spectrometry (HRMS) was performed 
using electrospray ionization (ESI) on a Waters Synapt mass spectrometer. Melting points were obtained 
using a Gehaka equipment model PF 1500 FARMA and were corrected. The compounds were named 
according to IUPAC rules using the software MarvinSketch version 16.11.21.  
 
General procedure for the preparation of tetrahydro-1H-xanthen-1-ones (3a-3g) and chromen-1-ones (3h-
3m/4a-4c). To a 5 mL round bottomed flask containing a stir-bar, the corresponding 2-hydroxybenzaldehyde 
(1.00 equiv.), the BIA catalyst (0.65 equiv.), prepared according to the procedure described by Zhang et al.,24 
sodium dodecyl sulfate (SDS, 0.10 equiv.) and the 2-cycloenone (2.00 equiv.) were added. Distilled water 
(1.0 mL) was then added and the reaction mixture was magnetically stirred at room temperature until 
complete consumption of the starting aldehyde or stagnation of the reaction. After that, the volatiles were 
evaporated under reduced pressure and the remaining residue was directly subjected to flash column 
chromatography purification to furnish the desired products, the structures of which are collected in 
Scheme 2. 
2,3,4,4a‐Tetrahydro‐1H‐xanthen‐1‐one (3a).17 Purified by column chromatography (hexane/EtOAc 98:2 → 
80:20) to give 3a (148 mg, 0.74 mmol, 74 %) as a yellow solid. When the reaction was performed on a larger 
scale (8.46 mmol of salicylaldehyde), compound 3a was obtained after 120 h in 63 % yield (1.071 g, 5.35 
mmol). Rf = 0.54 (4:1 hexane/EtOAc). Mp 136-138 °C (lit.17 Mp 137-139 °C). 1H NMR (250 MHz, CDCl3) δ 7.37 
Arkivoc 2020, ii, 0-0  Rodrigues, M. T. et al. 
 
 Page 8  ©AUTHORS 
(d, J 2.4 Hz, 1H), 7.27 – 7.10 (m, 2H), 7.01 – 6.78 (m, 2H), 4.94 (ddd, J 10.6, 6.0, 2.4 Hz, 1H), 2.69 – 2.21 (m, 
3H), 2.13 – 1.86 (m, 2H), 1.84 – 1.51 (m, 1H). 13C NMR (63 MHz, CDCl3) δ 197.3, 155.9, 132.0, 131.4, 130.4, 
129.8, 122.2, 122.1, 116.0, 74.6, 38.8, 29.7, 18.0. HRMS (ESI-TOF) m/z calcd for C13H13O2+ [M + H]+ 201.0910, 
found 201.0936. 
2,3,4,4a‐Tetrahydro‐5‐methoxy‐1H‐xanthen‐1‐one (3b).17 Purified by column chromatography 
(hexane/EtOAc 9:1) to give 3b (162 mg, 0.70 mmol, 70 %) as a yellow solid. Rf = 0.18 (4:1 hexane/EtOAc). Mp 
121-122 °C (lit.17 Mp 124-130 °C). 1H NMR (250 MHz, CDCl3) δ 7.25 (d, J 2.4 Hz, 1H), 6.73 (q, J 4.9 Hz, 3H), 
4.85 (ddd, J 10.6, 6.0, 2.4 Hz, 1H), 3.72 (s, 3H), 2.71 – 2.38 (m, 2H), 2.24 (ddd, J 18.3, 12.9, 5.8 Hz, 1H), 2.06 – 
1.81 (m, 2H), 1.50-1.63 (m, 1H). 13C NMR (63 MHz, CDCl3) δ 197.4, 147.8, 144.9, 131.5, 130.5, 122.9, 121.8, 
121.8, 114.6, 74.9, 56.1, 38.8, 29.7, 18.0. HRMS (ESI-TOF) m/z calcd for C14H15O3+ [M + H]+ 231.1016, found 
231.0998. 
2,3,4,4a-Tetrahydro-5-hydroxy-1H-xanthen-1-one (3c).17 Purified by column chromatography 
(hexane/EtOAc 95:5 → 60:40) to give 3c (158 mg, 0.73 mmol, 64 %) as a bright yellow solid. Mp 143-145 °C 
(lit.25 Mp 146-147 °C). Rƒ 0.32 (2:1 hexane/EtOAc). 1H NMR (250 MHz, CDCl3) δ 7.44 (d, J 2.4 Hz, 1H), 6.93 (dd, 
J 7.6, 2.1 Hz, 1H), 6.85 (t, J 7.6 Hz, 1H), 6.80 (dd, J 7.6, 2.1 Hz, 1H), 5.55 (s, 1H), 5.02 (ddd, J 10.6, 6.0, 2.4 Hz, 
1H), 2.70 – 2.54 (m, 1H), 2.54 – 2.31 (m, 2H), 2.19 – 1.94 (m, 2H), 1.82 – 1.59 (m, 1H). 13C NMR (63 MHz, 
CDCl3) δ 197.4, 144.1, 142.4, 131.8, 130.6, 122.4, 122.4, 121.3, 118.3, 75.5, 38.9, 29.7, 18.0. HRMS (ESI-TOF) 
m/z calcd for C13H13O3+ [M + H]+ 217.0859, found 217.0865.   
5‐Nitro‐2,3,4,4a‐tetrahydro‐1H‐xanthen‐1‐one (3d). Purified by column chromatography (hexane/EtOAc 
8:2) to give 3d (125 mg, 0.51 mmol, 51 %) as a yellow solid. Rf = 0.18 (4:1 hexane/EtOAc). Mp 139-140 °C. 1H 
NMR (250 MHz, CDCl3) δ 7.80 (dd, J 8.3, 1.6 Hz, 1H), 7.41 (dd, J 7.6, 1.7 Hz, 1H), 7.34 (d, J 2.5 Hz, 1H), 7.01 
(dd, J 8.3, 7.5 Hz, 1H), 5.12 (ddd, J 10.7, 5.9, 2.5 Hz, 1H), 2.83 – 2.52 (m, 2H), 2.40 (ddd, J 18.3, 13.0, 6.0 Hz, 
1H), 2.00-2.19 (m, 2H), 1.94 – 1.56 (m, 1H). 13C NMR (63 MHz, CDCl3) δ 196.9, 149.4, 138.5, 134.1, 132.0, 
129.2, 127.2, 124.7, 121.4, 75.9, 38.9, 29.5, 17.8. HRMS (ESI-TOF) m/z calcd for C13H12NO4+ [M + H]+ 
246.0761, found 246.0743. 
7‐Nitro‐2,3,4,4a‐tetrahydro‐1H‐xanthen‐1‐one (3e).17 Purified by column chromatography (hexane/EtOAc 
8:2) to give 3e (122 mg, 0.50 mmol, 50 %) as a yellow solid. Rf = 0.10 (4:1 hexane/EtOAc). Mp 197-198 °C, 
decomp. (lit.17 Mp 195-198 °C, decomp.). 1H NMR (250 MHz, CDCl3) δ 8.20 – 8.08 (m, 1H), 7.38 (d, J 2.5 Hz, 
1H), 6.96 (d, J 8.5 Hz, 1H), 5.18 (dd, J 11.0, 2.5 Hz, 1H), 2.74 – 2.35 (m, 1H), 2.25 – 1.95 (m, 1H), 1.87 – 1.63 
(m, 1H). 13C NMR (63 MHz, CDCl3) δ 196.9, 160.7, 142.5, 132.2, 129.1, 127.5, 125.3, 122.0, 116.8, 76.0, 39.0, 
29.9, 18.0. HRMS (ESI-TOF) m/z calcd for C13H12NO4+ [M + H]+ 246.0761, found 246.0771. 
6-Bromo-2,3,4,4a-tetrahydro-1H-xanthen-1-one (3f).25 Purified by column chromatography (hexane/EtOAc 
95:5 → 60:40) to give 3f (99 mg, 0.36 mmol, 36 %) as a pale yellow solid. Mp 107-108 °C (lit.25 Mp 119 °C). Rƒ 
0.53 (4:1 hexane/EtOAc). 1H NMR (500 MHz, CDCl3) δ 7.34 (d, J 2.2 Hz, 1H), 7.10 – 7.06 (m, 1H), 7.06 – 7.02 
(m, 2H), 4.98 (ddd, J 10.9, 6.1, 2.2 Hz, 1H), 2.58 (ddt, J 18.0, 4.4, 2.3 Hz, 1H), 2.53 – 2.44 (m, 1H), 2.37 (ddd, J 
18.1, 13.3, 6.1 Hz, 1H), 2.14 – 2.05 (m, 1H), 2.04 – 1.93 (m, 1H), 1.69 (qdd, J 13.5, 4.6, 2.6 Hz, 1H). 13C NMR 
(126 MHz, CDCl3) δ 197.3, 156.4, 130.7, 130.7, 130.6, 125.5, 125.4, 121.2, 119.6, 75.1, 38.9, 29.7, 18.0. HRMS 
(ESI-TOF) m/z calcd for C13H12BrO2+ [M + H]+ 279.0015, found 279.0031. 
(2E)-6-Bromo-2-[(4-bromo-2-hydroxyphenyl)methylidene]-2,3,4,4a-tetrahydro-1H-xanthen-1-one (4a). 
Purified by column chromatography (hexane/EtOAc 95:5 → 60:40) to give 4a (122 mg, 0.26 mmol, 53 %) as a 
viscous yellow oil. Rƒ 0.41 (4:1 hexane/EtOAc). 1H NMR (250 MHz, DMSO-d6) δ 1H NMR (250 MHz, DMSO) δ 
7.74 (d, J 2.5 Hz, 1H), 7.56 (d, J 2.3 Hz, 1H), 7.40 (d, J 8.2 Hz, 1H), 7.26 (d, J 8.2 Hz, 1H), 7.20 (dd, J 8.2, 1.9 Hz, 
1H), 7.14 (d, J 1.9 Hz, 1H), 7.09 (d, J 1.9 Hz, 1H), 7.05 (dd, J 8.2, 1.9 Hz, 1H), 5.26 (ddd, J 11.6, 5.1, 2.3 Hz, 1H), 
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2.93 (dt, J 7.6, 3.3 Hz, 1H), 2.74 – 2.55 (m, 1H), 2.46 – 2.33 (m, 1H), 2.00 – 1.79 (m, 2H). 13C NMR (63 MHz, 
DMSO-d6) δ 184.8, 157.9, 155.9, 134.0, 131.7, 131.7, 131.3, 131.2, 130.1, 125.2, 124.5, 123.1, 121.7, 121.6, 
121.5, 118.7, 118.3, 74.2, 28.4, 22.8. HRMS (ESI-TOF) m/z calcd for C20H15Br2O3+ [M + H]+ 460.9382, found 
460.9370. 
7a,8,9,10‐Tetrahydro‐11H‐benzo[a]xanthen‐11‐one (3g).17 Purified by column chromatography (hexane / 
EtOAc 9:1) to give 3g (27 mg, 0.10 mmol, 10 %) as a white solid. Rf = 0.30 (4:1 hexane/EtOAc). Mp 141-143 
°C (lit.17 Mp 142-146 °C). 1H NMR (250 MHz, CDCl3) δ 8.21 (d, J 2.2 Hz, 1H), 8.10 (dd, J 8.5, 1.1 Hz, 1H), 7.88 – 
7.74 (m, 2H), 7.58 (ddd, J 8.4, 6.9, 1.4 Hz, 1H), 7.46 – 7.38 (m, 1H), 7.14 (dd, J 8.9, 0.8 Hz, 1H), 5.09 (ddd, J 
10.1, 6.2, 2.2 Hz, 1H), 2.74 – 2.37 (m, 3H), 2.26 – 2.04 (m, 2H), 1.91 – 1.72 (m, 1H). 13C NMR (63 MHz, CDCl3) 
δ 197.4, 155.7, 133.3, 131.6, 129.7, 128.9, 128.7, 128.0, 127.6, 124.8, 122.2, 117.5, 116.0, 74.9, 38.9, 29.6, 
18.2. HRMS (ESI-TOF) m/z calcd for C17H14NaO2+ [M + Na]+ 273.0886, found 273.0895. 
3,3a-Dihydrocyclopenta[b]chromen‐1(2H)‐one (3h).17 Purified by column chromatography (hexane/EtOAc 
9:1 → 7:3) to give 3h (73 mg, 0.70 mmol, 39 %) as a yellow solid. Rf = 0.33 (4:1 hexane/EtOAc). Mp 114-116 
°C (lit.17 Mp 107-110 °C).1H NMR (250 MHz, CDCl3) δ 7.36 – 7.16 (m, 1H), 7.09 – 6.80 (m, 1H), 5.30 (td, J 8.2, 
7.6, 2.5 Hz, 1H), 2.89 – 2.54 (m, 1H), 2.45 – 1.99 (m, 1H). 13C NMR (63 MHz, CDCl3) δ 201.6, 155.5, 132.6, 
131.9, 130.6, 127.8, 122.5, 122.1, 116.7, 75.9, 37.2, 28.3. HRMS (ESI-TOF) m/z calcd for C12H11O2+ [M + H]+ 
187.0754, found 187.0758. 
(2E)‐3,3a-Dihydro-2‐[(2‐Hydroxyphenyl)methylidene]cyclopenta[b]chromen‐1(2H)‐one (4b).26 Purified by 
column chromatography (hexane/EtOAc 9:1 → 7:3) to give 4b (72 mg, 0.25 mmol, 50 %) as an orange solid. 
Rf 0.21 (7:3 hexane/EtOAc). Mp 160-164 °C, decomp.  1H NMR (250 MHz, CDCl3/MeOH-d4 6:1) δ 8.03 (t, J 2.7 
Hz, 1H), 7.62 – 7.37 (m, 1H), 7.38 – 7.13 (m, 4H), 7.13 – 6.78 (m, 4H), 5.60 – 5.13 (m, 1H), 3.59 (ddd, J 16.7, 
8.2, 2.1 Hz, 1H), 3.09 (ddd, J 16.8, 6.9, 3.5 Hz, 1H). 13C NMR (63 MHz, CDCl3/MeOH-d4 6:1) δ 192.2, 158.2, 
156.0, 135.5, 134.1, 132.9, 132.2, 131.7, 130.9, 130.3, 129.2, 123.0, 122.9, 120.0, 117.1, 116.3, 74.5, 35.5. 
HRMS (ESI-TOF) m/z calcd for C19H15O3+ [M + H]+ 291.1016, found 291.1021. 
3,3a-Dihydro-5‐methoxycyclopenta[b]chromen‐1(2H)‐one (3i). Purified by column chromatography 
(hexane/EtOAc 9:1) to give 3i (61 mg, 0.28 mmol, 28 %) as a yellow solid. Rf = 0.16 (4:1 hexane/EtOAc). Mp 
143-146 °C. 1H NMR (250 MHz, CDCl3) δ 7.13 (d, J 2.5 Hz, 1H), 6.92 – 6.75 (m, 3H), 5.35 – 5.20 (m, 1H), 3.84 
(s, 3H), 2.89 – 2.66 (m, 1H), 2.71 – 2.44 (m, 1H), 2.37 – 2.07 (m, 2H). 13C NMR (63 MHz, CDCl3) δ 201.5, 148.4, 
144.4, 131.9, 127.8, 122.8, 122.4, 122.1, 115.1, 76.2, 56.3, 37.2, 28.4. HRMS (ESI-TOF) m/z calcd for 
C13H13O3+ [M + H]+ 217.0859, found 263.1189. 
(2E)‐2‐[(2‐Hydroxy‐3‐methoxyphenyl)methylidene]‐5‐methoxycyclopenta[b]chromen‐1(2H)‐one (4c). 
Purified by column chromatography (hexane/EtOAc 9:1) to give 4c (70 mg, 0.20 mmol, 40 %) as a yellow 
solid. Rf = 0.15 (7:3 hexane/EtOAc). Mp 171-175 °C, decomp. 1H NMR (400 MHz, CDCl3) δ 8.04 (dd, J 3.6, 2.0 
Hz, 1H), 7.38 (d, J 2.5 Hz, 1H), 7.11 (dd, J 6.3, 3.1 Hz, 1H), 7.04 – 6.86 (m, 5H), 6.15 (s, 1H), 5.33 (ddd, J 8.2, 
6.7, 2.9 Hz, 1H), 3.94 (d, J 3.3 Hz, 6H), 3.73 (ddd, J 16.9, 8.2, 2.0 Hz, 1H), 3.28 (ddd, J 16.9, 6.8, 3.5 Hz, 1H). 13C 
NMR (101 MHz, CDCl3) δ 190.7, 148.5, 146.9, 146.3, 144.6, 136.3, 134.0, 129.4, 128.3, 123.5, 122.4, 122.2, 
121.9, 121.8, 119.7, 114.9, 112.0, 74.5, 56.4, 35.6. HRMS (ESI-TOF) m/z calcd for C21H19O5+ 351.1227 [M + 
H]+, found 351.1232. CCDC 1980794 contains the supplementary crystallographic data for this paper. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/structures. 
3,3a-Dihydro-5‐nitrocyclopenta[b]chromen‐1(2H]‐one (3j). Purified by column chromatography 
(hexane/EtOAc 8:2) to give 3j (36 mg, 0.18 mmol, 18 %) as a yellow solid. Rf 0.15 (4:1 hexane/EtOAc). Mp 
195-197 °C. 1H NMR (250 MHz, CDCl3) δ 7.85 (dd, J 8.2, 1.6 Hz, 1H), 7.70 – 7.42 (m, 1H), 7.22 (d, J 2.6 Hz, 1H), 
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7.07 (t, J 7.9 Hz, 1H), 5.61 – 5.30 (m, 1H), 2.95 – 2.58 (m, 2H), 2.54 – 2.17 (m, 2H). 13C NMR (63 MHz, CDCl3) δ 
200.7, 149.0, 139.3, 134.7, 133.4, 127.7, 125.8, 124.7, 121.7, 76.8, 37.2, 28.1. HRMS (ESI-TOF) m/z calcd for 
C12H10NO4+ [M + H]+ 232.0604, found 232.0657. 
2‐[Hydroxy(2‐hydroxy‐3‐nitrophenyl)methyl]cyclopent‐2‐en‐1‐one (5a). Purified by column chromato-
graphy (hexane/EtOAc 9:1) to give 5a (75 mg, 0.30 mmol, 30 %) as a viscous yellow oil. Rf 0.21 (1:1 
hexane/EtOAc). 1H NMR (500 MHz, CDCl3) δ 10.96 (s, 1H), 8.04 (dd, J 8.5, 1.7 Hz, 1H), 7.83 (dd, J 7.5, 1.7 Hz, 
1H), 7.38 (td, J 2.7, 1.1 Hz, 1H), 7.02 (dd, J 8.5, 7.5 Hz, 1H), 5.91 (s, 1H), 4.17 (brs, 1H), 2.70 – 2.55 (m, 2H), 
2.52 – 2.40 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 210.0, 160.2, 152.0, 145.2, 135.4, 133.6, 132.4, 124.4, 
120.0, 64.8, 35.3, 26.8. HRMS (ESI-TOF) m/z calcd for C12H11NNaO5+ 272.0529 [M + Na]+, found 272.0525. 
3,3a-Dihydro-7‐nitrocyclopenta[b]chromen‐1(2H]‐one (3k).27 Purified by column chromatography (hexane / 
EtOAc 8:2) to give 3k (50 mg, 0.22 mmol, 22 %) as a yellow solid. Rf 0.18 (4:1 hexane/EtOAc). Mp 175-177 °C. 
1H NMR (250 MHz, CDCl3) δ 8.14 (dd, J 4.7, 2.3 Hz, 1H), 7.19 (d, J 2.6 Hz, 1H), 7.00 (d, J 9.7 Hz, 1H), 5.42 (ddd, 
J 9.6, 8.0, 2.6 Hz, 1H), 3.03 – 2.58 (m, 1H), 2.52 – 2.13 (m, 1H). 13C NMR (63 MHz, CDCl3) δ 200.4, 160.2, 
142.6, 133.4, 127.8, 125.9, 125.5, 121.9, 117.3, 76.8, 37.0, 28.2. HRMS (ESI-TOF) m/z calcd for C12H9NNaO4+ 
[M + Na]+ 254.0424, found 254.0452. 
2‐[Hydroxy-(2‐hydroxy‐5‐nitrophenyl)methyl]cyclopent‐2‐en‐1‐one (5b). Purified by column chromato-
graphy (hexane/EtOAc 6:4) to give 5b (62 mg, 0.25 mmol, 25 %) as a viscous yellow oil. Rf = 0.16 (1:1 
hexane/EtOAc). 1H NMR (250 MHz, CDCl3) δ 9.26 (brs, 1H), 8.24 – 7.94 (m, 2H), 7.39 (s, 1H), 7.00 (d, J 8.8 Hz, 
1H), 5.87 (s, 1H), 2.70 (dt, J 4.3, 2.1 Hz, 2H), 2.66 – 2.44 (m, 2H). 13C NMR (63 MHz, CDCl3) δ 211.3, 161.7, 
145.3, 141.1, 125.8, 123.8, 118.7, 69.2, 35.5, 27.3. HRMS (ESI-TOF) m/z calcd for C12H11NNaO5+ 272.0529 [M 
+ Na]+, found 272.0561. 
8,9-Dihydrobenzo[f]cyclopenta[b]chromen-10(7aH]-one (3l).28 Purified by column chromatography 
(hexane/EtOAc 8:2) to give 3l (24 mg, 0.10 mmol, 10 %) as a yellow solid. Rf = 0.32 (4:1 hexane/EtOAc). Mp 
138-139 °C. 1H NMR (500 MHz, CDCl3) δ 8.09 – 8.00 (m, 1H), 7.95 (d, J 2.4 Hz, 1H), 7.91 – 7.79 (m, 2H), 7.59 
(ddd, J 8.4, 6.9, 1.3 Hz, 1H), 7.44 (ddd, J 8.0, 6.8, 1.1 Hz, 1H), 7.16 (d, J 8.8 Hz, 1H), 5.43 (td, J 8.0, 2.4 Hz, 1H), 
2.88 – 2.76 (m, 1H), 2.73 – 2.63 (m, 1H), 2.45 (ddd, J 18.3, 12.3, 8.7 Hz, 1H), 2.35 – 2.21 (m, 1H). 13C NMR 
(126 MHz, CDCl3) δ 201.4, 154.7, 133.4, 131.7, 129.6, 129.1, 128.8, 128.0, 124.7, 124.5, 121.9, 117.6, 115.7, 
76.1, 37.3, 28.0. HRMS (ESI-TOF) m/z calcd for C16H13O2+ 237.0910 [M + H]+, found 237.0932. 
6,7,8,9-Tetrahydrocyclohepta[b]chromen‐10(5aH]‐one (3m). Purified by column chromatography (hexane / 
EtOAc 8:2) to give 3m (28 mg, 0.13 mmol, 13 %) as an orange solid. Rf = 0.37 (4:1 hexane/EtOAc). Mp 51-57 
°C. 1H NMR (250 MHz, CDCl3) δ 7.27 – 7.09 (m, 2H), 6.90 (td, J 7.4, 1.1 Hz, 1H), 6.80 (d, J 8.1 Hz, 1H), 5.26 (dd, 
J 10.8, 2.7 Hz, 1H), 2.80 – 2.58 (m, 1H), 2.49 (ddd, J 14.2, 12.1, 2.1 Hz, 1H), 2.31 – 1.90 (m, 4H), 1.82 – 1.50 
(m, 2H). 13C NMR (63 MHz, CDCl3) δ 199.4, 154.1, 134.7, 132.2, 129.8, 129.4, 121.7, 120.3, 116.2, 77.6, 43.5, 
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